Identification and Characterization of Nonalcoholic Fatty Liver Disease.


Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
07 2020
Historique:
received: 02 06 2019
revised: 04 08 2019
accepted: 06 08 2019
pubmed: 14 8 2019
medline: 19 8 2021
entrez: 13 8 2019
Statut: ppublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) is characterized by substantial diagnostic and evaluation gaps with no systematic screening. Even recognized cases are undercoded because of the perceived benign nature of disease and current absence of approved pharmacologic treatment. NAFLD is often detected incidentally, particularly in the asymptomatic early phase. We doubled NAFLD detection via natural language processing of 1 million imaging reports combined with laboratory data from an unselected population. We describe NAFLD comorbidities and health care utilization as compared with age, sex, and body mass index matched control subjects.

Identifiants

pubmed: 31404663
pii: S1542-3565(19)30863-8
doi: 10.1016/j.cgh.2019.08.007
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1887-1889

Informations de copyright

Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Inbal Goldshtein (I)

Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel. Electronic address: goldst_in@mac.org.il.

Gabriel Chodick (G)

Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ilan Kochba (I)

Gilead Sciences, Europe, Middle East and Africa Medical Affairs, Hod-Hasharon, Israel.

Nitsan Gal (N)

Gilead Sciences, Europe, Middle East and Africa Medical Affairs, Hod-Hasharon, Israel.

Muriel Webb (M)

Radiology Institute, Maccabi Healthcare Services, Tel Aviv, Israel; Department of Gastroenterology and Hepatology, Tel Aviv-Sourasky Medical Center, Tel Aviv, Israel.

Oren Shibolet (O)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Gastroenterology and Hepatology, Tel Aviv-Sourasky Medical Center, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH